Physician profile
Patrick Brooks
NPI 1063975043
$16,414.44
in general payments reported to CMS, 2019-2025
10 companies · $5,505 in 2025
The $5,505 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2022: $1,883 · 2023: $794 · 2024: $8,127 · 2025: $5,505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $2,705 · Travel and Lodging: $1,722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $2,704.91 |
| Travel and Lodging | $1,721.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11,602.04 | 2024-2025 | Journey II, Real Intelligence, Or3o Dual Mobility |
| Stryker Corporation | $1,945.92 | 2022-2025 | Mako, Gamma, T2 |
| Arthrex, INC. | $1,652.68 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $504.92 | 2023-2025 | Persona, Rosa, Arcos |
| Depuy Synthes Sales INC. | $216.35 | 2024-2025 | Attune, Tfn-Advance, Na |
| Team 1, LLC | $152.72 | 2025 | |
| Innovation Technologies INC | $133.64 | 2023 | Irrisept |
| Depuy Synthes Products, INC. | $90.46 | 2024 | Velys |
| Integra Lifesciences Corporation | $73.25 | 2024 | Biofix, Biodfactor, Biodoptix |
| Reel Surgical, INC. | $42.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.